BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35563491)

  • 1. Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters.
    Meyer MJ; Falk S; Römer S; Prinzinger C; Tacke S; Geyer J; Simm S; Tzvetkov MV
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.
    Jensen O; Rafehi M; Tzvetkov MV; Brockmöller J
    Biochem Pharmacol; 2020 Jan; 171():113731. PubMed ID: 31783011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
    Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
    Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1.
    Meyer MJ; Schreier PCF; Basaran M; Vlasova S; Seitz T; Brockmöller J; Zdrazil B; Tzvetkov MV
    J Biol Chem; 2022 Jun; 298(6):101974. PubMed ID: 35469921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
    Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
    Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
    Nies AT; Herrmann E; Brom M; Keppler D
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
    Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
    Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
    Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
    Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
    Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
    Choi MK; Song IS
    Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.
    Gebauer L; Arul Murugan N; Jensen O; Brockmöller J; Rafehi M
    Biochem Pharmacol; 2022 Mar; 197():114871. PubMed ID: 34902340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
    Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
    Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
    König J; Zolk O; Singer K; Hoffmann C; Fromm MF
    Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.
    Meyer MJ; Seitz T; Brockmöller J; Tzvetkov MV
    PLoS One; 2017; 12(12):e0189521. PubMed ID: 29236753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
    Urakami Y; Okuda M; Masuda S; Saito H; Inui KI
    J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients.
    Jung N; Lehmann C; Rubbert A; Schömig E; Fätkenheuer G; Hartmann P; Taubert D
    Infection; 2013 Apr; 41(2):379-85. PubMed ID: 22875535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
    Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
    Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
    Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
    J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2.
    Suo Y; Wright NJ; Guterres H; Fedor JG; Butay KJ; Borgnia MJ; Im W; Lee SY
    Nat Struct Mol Biol; 2023 Jul; 30(7):1001-1011. PubMed ID: 37291422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.